摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxybutyl 2-cyanoacetate | 872031-81-7

中文名称
——
中文别名
——
英文名称
4-hydroxybutyl 2-cyanoacetate
英文别名
4-Hydroxybutyl cyanoacetate
4-hydroxybutyl 2-cyanoacetate化学式
CAS
872031-81-7
化学式
C7H11NO3
mdl
——
分子量
157.169
InChiKey
SPVWLYKDBKCXOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    317.1±22.0 °C(Predicted)
  • 密度:
    1.135±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    11
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    70.3
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    4-hydroxybutyl 2-cyanoacetate氢氧化钾 作用下, 以 乙醇 为溶剂, 生成 (E)-2-Cyano-3-(2-methyl-benzofuran-5-ylamino)-3-methylsulfanyl-acrylic acid 4-hydroxy-butyl ester
    参考文献:
    名称:
    Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors
    摘要:
    N,N'-Disubstituted ketene aminals are good bioisosteres of thiourea functional groups. We report the design and synthesis of a novel class of ketene aminal-based lactam derivatives as potent and orally active FXa inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.08.107
  • 作为产物:
    描述:
    1,4-丁二醇氰乙酸草酰氯N,N-二甲基甲酰胺三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 19.16h, 以50%的产率得到4-hydroxybutyl 2-cyanoacetate
    参考文献:
    名称:
    用于单一材料有机太阳能电池的C 60-小芳基胺推拉二元组
    摘要:
    描述了两个二元体的合成,这些二元体通过酯化反应形成的柔性绝缘连接基团连接,包括小的基于芳基胺的推挽系统作为供体嵌段和C 60富勒烯作为受体。在通过循环伏安法和UV-Vis吸收光谱法分析了它们的电子特性后,已经在简单的直接结构装置中评估了这些分子作为单材料有机太阳能电池活性材料的潜力。基本上由于填充因子差,这两种方法均导致约0.40%的适中转换效率。就供体和受体嵌段的纳米相分离不足以及与连接C 60连续的供体嵌段的空穴迁移率下降而言,讨论了这些结果。
    DOI:
    10.1016/j.dyepig.2019.107748
点击查看最新优质反应信息

文献信息

  • CURED PRODUCT, OPTICAL MEMBER, LENS, COMPOUND, AND CURABLE COMPOSITION
    申请人:FUJIFILM Corporation
    公开号:US20200199095A1
    公开(公告)日:2020-06-25
    According to the present invention, a cured product obtained by curing a curable composition including a compound represented by General Formula 1, in which a birefringence Δn (587 nm) is 0.00≤Δn (587 nm)≤0.01, is provided, and this cured product is suitable for manufacturing an optical member. Pol 1 -Sp 1 -L 1 -Ar-L 2 -Sp 2 -Pol 2 (General Formula 1 ) In formula, Ar is an aromatic ring group represented by General Formula 2-2 and the like. In formula, Z 1 and Z 2 each represent a hydrogen atom, a methyl group, and the like; A 1 and A 2 each represent —S— and the like; X represents C(Rz) 2 and the like (where Rz is a substituent, and two Rz's may form a ring); L 1 and L 2 each represent a single bond, —O—, —OC(═O)—, —OC(═O)O—, —OC(═O)NH—, and the like; Sp 1 and Sp 2 each represent a single bond or a divalent linking group; Pol 1 and Pol 2 each represent a hydrogen atom or a polymerizable group; and a compound represented by General Formula 1 has at least one polymerizable group.
    根据本发明,通过固化包括通式1所代表的化合物的可固化组合物获得的固化产品,其中双折射Δn(587 nm)为0.00≤Δn(587 nm)≤0.01,提供,并且该固化产品适用于制造光学元件。 Pol1-Sp1-L1-Ar-L2-Sp2-Pol2(通式1) 在公式中,Ar是由通式2-2等表示的芳香环基团。 在公式中,Z1和Z2分别表示氢原子,甲基基团等;A1和A2分别表示—S—等;X表示C(Rz)2等(其中Rz是取代基,两个Rz可能形成环);L1和L2分别表示单键,—O—,—OC(═O)—,—OC(═O)O—,—OC(═O)NH—等;Sp1和Sp2分别表示单键或二价连接基团;Pol1和Pol2分别表示氢原子或可聚合基团;并且由通式1所代表的化合物至少具有一个可聚合基团。
  • Cured product, optical member, lens, compound, and curable composition
    申请人:FUJIFILM Corporation
    公开号:US11078180B2
    公开(公告)日:2021-08-03
    According to the present invention, a cured product obtained by curing a curable composition including a compound represented by General Formula 1, in which a birefringence Δn (587 nm) is 0.00≤Δn (587 nm)≤0.01, is provided, and this cured product is suitable for manufacturing an optical member. Pol1-Sp1-L1-Ar-L2-Sp2-Pol2  (General Formula 1) In formula, Ar is an aromatic ring group represented by General Formula 2-2 and the like. In formula, Z1 and Z2 each represent a hydrogen atom, a methyl group, and the like; A1 and A2 each represent —S— and the like; X represents C(Rz)2 and the like (where Rz is a substituent, and two Rz's may form a ring); L1 and L2 each represent a single bond, —O—, —OC(═O)—, —OC(═O)O—, —OC(═O)NH—, and the like; Sp1 and Sp2 each represent a single bond or a divalent linking group; Pol1 and Pol2 each represent a hydrogen atom or a polymerizable group; and a compound represented by General Formula 1 has at least one polymerizable group.
    根据本发明,提供了一种通过固化包含通式 1 所表示的化合物的可固化组合物而获得的固化产品,其中双折射 Δn (587 nm) 为 0.00≤Δn (587 nm)≤0.01 ,该固化产品适用于制造光学部件。 Pol1-Sp1-L1-Ar-L2-Sp2-Pol2 (通式 1) 式中,Ar 是由通式 2-2 及类似通式表示的芳香环基。 式中,Z1 和 Z2 分别代表氢原子、甲基等;A1 和 A2 分别代表-S-等;X 代表 C(Rz)2 等(其中 Rz 是取代基,两个 Rz 可形成一个环);L1 和 L2 分别代表单键、-O-、-OC(═O)-、-OC(═O)O-、-OC(═O)NH- 等;Sp1和Sp2各自代表单键或二价连接基团;Pol1和Pol2各自代表氢原子或可聚合基团;通式1所代表的化合物具有至少一个可聚合基团。
  • Rigidified merocyanine dyes with different aspect ratios: Dichroism and photostability
    作者:Katharina Christina Kreß、Korinna Bader、Joachim Stumpe、S. Holger Eichhorn、Sabine Laschat、Thomas Fischer
    DOI:10.1016/j.dyepig.2015.04.041
    日期:2015.10
    A series of new rigidified merocyanines were investigated with regard to their optical properties as dichroic dyes. Guest/host-mixtures of the dyes were prepared using a liquid crystal and a reactive mesogen mixture. Their dichroism was studied using linearly-polarized UV/Vis-spectroscopy. A strong dependence of the dichroic ratio on the aspect ratio, the number of double bonds in the molecular structure, and on the maximum wavelength of absorption was found. A strategy to increase the aspect ratio has also been demonstrated. Additionally, the photostability was characterized using continued irradiation with polychromatic light from a xenon source. High photostability was found in all host mixtures in the absence of oxygen by alignment in a matrix. The suitability for their application as dichroic dyes in thin layer polarizers and guest/host-displays is herein discussed. (C) 2015 Elsevier Ltd. All rights reserved.
  • OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM
    申请人:SUZUKI Hiroyuki
    公开号:US20090202921A1
    公开(公告)日:2009-08-13
    The present invention provides an optical recording composition comprising at least one compound denoted by general formula (I) and a holographic recording medium comprising a recording layer, wherein the recording layer comprises at least one compound denoted by general formula (I). In general formula (I), each of A 1 and A 2 independently denotes —CR 4 R 5 —, —O—, —NR 6 —, —S—, or —C(═O)—, each of R 4 , R 5 , and R 6 independently denotes a hydrogen atom or a substituent, R 1 denotes a substituent, n denotes an integer ranging from 0 to 4, each of R 2 and R 3 independently denotes a substituent having a Hammett substituent constant, σp value, of greater than 0, R 2 and R 3 do not form a ring structure by bonding together, and at least one from among R 1 , R 2 , R 3 , A 1 , and A 2 comprises at least one polymerizable group.
  • Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors
    作者:Yan Shi、Jing Zhang、Philip D. Stein、Mengxiao Shi、Stephen P. O’Connor、Sharon N. Bisaha、Chi Li、Karnail S. Atwal、Gregory S. Bisacchi、Doree Sitkoff、Andrew T. Pudzianowski、Eddie C. Liu、Karen S. Hartl、Steven M. Seiler、Sonia Youssef、Thomas E. Steinbacher、William A. Schumacher、Alan R. Rendina、Jeffrey M. Bozarth、Tara L. Peterson、Ge Zhang、Robert Zahler
    DOI:10.1016/j.bmcl.2005.08.107
    日期:2005.12
    N,N'-Disubstituted ketene aminals are good bioisosteres of thiourea functional groups. We report the design and synthesis of a novel class of ketene aminal-based lactam derivatives as potent and orally active FXa inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物